Thienopyridines
Advanced Chemblocks Inc 4-AMINO-3-BROMOTHIENO 3,2-C 5G
4-AMINO-3-BROMOTHIENO[3,2-C]PYRIDINE, 799293-85-9, MFCD08275115
![eMolecules ChemScene / Furo[32-b]pyridine-6-carboxylic acid / 100mg / 632295551 / CS-0155526 / 0.000 / 122535-04-0 / MFCD13193320 / 163.132 / C8H5NO3](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502451279.PNG-250.jpg)
eMolecules ChemScene / Furo[32-b]pyridine-6-carboxylic acid / 100mg / 632295551 / CS-0155526 / 0.000 / 122535-04-0 / MFCD13193320 / 163.132 / C8H5NO3
ChemScene / Furo[32-b]pyridine-6-carboxylic acid / 100mg / 632295551 / CS-0155526 / 0.000 / 122535-04-0 / MFCD13193320 / 163.132 / C8H5NO3
Medchemexpress LLC AMI-1 | 20324-87-2 | 98.0% | 548.45 | 25 MG
AMI-1 is a potent, cell-permeable, and reversible inhibitor of protein arginine N-methyltransferases (PRMTs), with IC50s of 8.8 μM for human PRMT1 and 3.0 μM for yeast-Hmt1p. It inhibits PRMTs by blocking peptide-substrate binding.
- Potent, cell-permeable, and reversible inhibitor
- Inhibits in vitro methylation reactions performed by PRMT1, -3, -4, -6, and Hmt1p
- Inhibits both type I and type II PRMTs
- Specifically inhibits arginine methyltransferase activity
- Does not compete for the AdoMet binding site
- Inhibits methylation of GFP-Npl3 and cellular proteins
![eMolecules Thieno[3,2-d]pyrimidin-4-amine | 16285-74-8 | MFCD09834952 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502191082.JPG-250.jpg)
eMolecules Thieno[3,2-d]pyrimidin-4-amine | 16285-74-8 | MFCD09834952 | 1g
Combi-Blocks | Thieno[3,2-d]pyrimidin-4-amine | 1g | 232336110 | ST-4220 | 97.000 | 16285-74-8 | MFCD09834952 | 151.190 | C6H5N3S
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC human GIP(3-30), amide | 1884226-05-4 | 99.8% | 3297.69 | 10 MG
Human GIP(3-30), amide is a high-affinity antagonist of the human GIP receptor in vitro, with potential anti-obesity and anti-diabetic effects. It competitively binds to the GIP receptor, inhibiting GIP-mediated cAMP accumulation, β-arrestin recruitment, and receptor internalization. It also inhibits GIP-mediated insulin secretion and signal transduction in adipocytes.
- High-affinity antagonist of human GIP receptor.
- Potential anti-obesity and anti-diabetic effects.
- Inhibits GIP-mediated cAMP accumulation and insulin secretion.
- Purity of 99.8%.
- Powder storage: -80°C for 2 years or -20°C for 1 year.
- For research use only.
Medchemexpress LLC Human GIP(3-30), amide TFA | 1884226-05-4 | 95.6% | 3297.69 | 5 MG
Human GIP(3-30), amide TFA is the TFA salt form of human GIP(3-30), amide. It is a high affinity antagonist of the human GIP receptor in vitro and has potential anti-obesity and anti-diabetic effects.
- High affinity antagonist of the human GIP receptor in vitro.
- Potential anti-obesity and anti-diabetic effects.
- Competitively binds to GIP receptor (GIPR), blocking GIP-mediated cAMP accumulation (Ki=16.8 nM), β-arrestin recruitment (Ki for β-arrestin-1/2 recruitment is 10.6 nM and 10.2 nM) and receptor internalization.
- Inhibits GIP mediated insulin secretion and signal transduction in adipocytes.